Clinical effect of decitabine in the treatment of myelodysplastic syndrome and influencing factors

机译：地西他滨治疗骨髓增生异常综合征的临床疗效及影响因素

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

To analyze the effect of decitabine combined with conventional chemotherapy on myelodysplastic syndrome (MDS) and its influencing factors.

机译：分析地西他滨联合常规化疗对骨髓增生异常综合症（MDS）的影响及其影响因素。

著录项

期刊名称 Pakistan Journal of Medical Sciences
作者
Tangxia Liu; Jing Wang; Chunmei Li; Lingzhi Jia;
展开▼
作者单位

展开▼
年(卷),期 2020(36),5
年度 2020
页码 -1
总页数 5
原文格式 PDF
正文语种
中图分类基础医学;
关键词
Decitabine; Myelodysplastic syndrome; CAG; Scheme;

机译：地西他滨;骨髓增生异常综合症;CAG;方案;

相似文献

外文文献
中文文献
专利

1. Clinical effect of decitabine in the treatment of myelodysplastic syndrome and influencing factors [J] . Tangxia Liu, Jing Wang, Chunmei Li, Pakistan journal of medical sciences. . 2020,第5期

机译：去甲滨治疗骨髓增生综合征及影响因素的临床疗效
2. Key clinical observations after 5-azacytidine and decitabine treatment of myelodysplastic syndromes suggest practical solutions for better outcomes [J] . Yogen Saunthararajah Hematology . 2013,第1期

机译：5-氮胞苷和地西他滨治疗骨髓增生异常综合症后的主要临床观察结果提示了可行的解决方案，可改善治疗效果
3. A novel treatment regimen of granulocyte colony-stimulating factor combined with ultra-low-dose decitabine and low-dose cytarabine in older patients with acute myeloid leukemia and myelodysplastic syndromes [J] . Huan Zhu, Bin Yang, Jia Liu, Therapeutic advances in hematology. . 2021,第a期

机译：粒细胞菌落刺激因子的新型治疗方案与急性髓性白血病和骨髓增强综合征的老年患者的超低剂量去蛋白和低剂量红细胞红宝石合并
4. Azanudeoside DNA Methyltransferase Inhibitor Drugs: Update on Clinical Applications in Myelodysplastic Syndromes and Acute Myeloid Leukemia [C] . Michael Lubbert, Michael Daskalakis, Philipp N. Ser, Weissenburg Symposium Biriciana . 2016

机译：硫代稳产苷DNA甲基转移酶抑制剂药物：更新骨髓增生综合征和急性髓性白血病的临床应用
5. Evaluation of epidemiological and clinical factors in survival of patients with de novo myelodysplastic syndrome at the University of Texas MD Anderson cancer center. [D] . Sunder, Suraj. 2009

机译：德克萨斯大学MD安德森癌症中心评估从头骨髓增生异常综合症患者生存的流行病学和临床因素。
6. A novel treatment regimen of granulocyte colony-stimulating factor combined with ultra-low-dose decitabine and low-dose cytarabine in older patients with acute myeloid leukemia and myelodysplastic syndromes [O] . Huan Zhu, Bin Yang, Jia Liu, 2021

机译：粒细胞菌落刺激因子的新型治疗方案与老年骨髓白血病和髓细胞增强综合症的老年患者超低剂量脱蛋白和低剂量含有低剂量红霉菌症
7. Disparity in perceptions of disease characteristics, treatment effectiveness, and factors influencing treatment adherence between physicians and patients with myelodysplastic syndromes [O] . David P. Steensma, Rami S. Komrokji, Richard M. Stone, 2014

机译：在疾病特征，治疗效果和影响医生和骨髓增生患者患者之间的因素的看似性差异
8. Submittal for myelodysplastic syndromes (MDS) among people reporting exposure to toluene/xylene and other independent risk factors. [R] . 2015

机译：在报告接触甲苯/二甲苯和其他独立危险因素的人群中提交myelodysplastic综合征（mDs）。

Clinical effect of decitabine in the treatment of myelodysplastic syndrome and influencing factors

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅